Camrese Lo extended-cycle and Perflutren Lipid Microspheres
Determining the interaction of Camrese Lo extended-cycle and Perflutren Lipid Microspheres and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ethinyl estradiol / levonorgestrel
Brand name: Amethia, Amethia Lo, Camrese, Camrese Lo, Daysee, Introvale, Jolessa, LoSeasonique, Quartette, Quasense, Seasonale, Seasonique, Afirmelle, Altavera, Amethyst, Ashlyna, Aubra, Aubra EQ, Aviane, Ayuna, Balcoltra, Chateal, Chateal EQ, Delyla, Enpresse-28, FaLessa, Falmina, Fayosim, Kurvelo, Larissia, Lessina, Levonest, Levora 015/30, Lillow, Lutera, Marlissa, Myzilra, Orsythia, Portia-28, Rivelsa, Setlakin, Simpesse, Sronyx, Trivora, Vienva, Alesse, Enpresse, Levlen, Levora, Lybrel, Nordette, Portia, Tri-Levlen, Triphasil-21, Triphasil-28, Trivora-28, Preven EC, Triphasil
Synonyms: Camrese Lo (extended-cycle), Camrese Lo
Generic Name: perflutren
Brand name: Definity, Optison
Synonyms: Perflutren
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Camrese Lo extended-cycle-Perflutren Protein Type A
- Camrese Lo extended-cycle-Perflutren protein type a microsphere Intravenous
- Camrese Lo extended-cycle-Perforomist
- Camrese Lo extended-cycle-Perforomist, Symbicort
- Camrese Lo extended-cycle-Pergolide
- Camrese Lo extended-cycle-Pergonal
- Perflutren Lipid Microspheres-Canagliflozin
- Perflutren Lipid Microspheres-Canagliflozin and metformin
- Perflutren Lipid Microspheres-Canagliflozin and Metformin Extended-Release Tablets
- Perflutren Lipid Microspheres-Canagliflozin and Metformin Tablets
- Perflutren Lipid Microspheres-Canakinumab
- Perflutren Lipid Microspheres-Canakinumab Subcutaneous